Trial Outcomes & Findings for Safety and Efficacy of Laryngeal Mask Airways in Sinonasal Surgery (NCT NCT02311153)

NCT ID: NCT02311153

Last Updated: 2018-06-01

Results Overview

Presence or absence of blood/secretions as noted in trachea and larynx. Patients were evaluated based on a soiling score completed by the surgeon, ranging from 0 (no contamination or soilage) to 3 (contamination of the tube/bloody secretions).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

104 participants

Primary outcome timeframe

intraoperative, within about 1 hour

Results posted on

2018-06-01

Participant Flow

Recruitment was completed in clinic and the pre-operative surgical area.

2 patients were consented and enrolled in the clinic setting, but they did not end up being randomized: 1 did not proceed with surgery 1 was diagnosed with sleep apnea, which is exclusionary

Participant milestones

Participant milestones
Measure
Endotracheal Intubation
Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure Mallinckrodt Endotracheal Tube (ETT): Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.
Laryngeal Mask Airway
Laryngeal mask for airway management and ventilation during sinonasal surgical procedure Laryseal Laryngeal mask airway (LMA): Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.
Overall Study
STARTED
53
49
Overall Study
COMPLETED
48
42
Overall Study
NOT COMPLETED
5
7

Reasons for withdrawal

Reasons for withdrawal
Measure
Endotracheal Intubation
Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure Mallinckrodt Endotracheal Tube (ETT): Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.
Laryngeal Mask Airway
Laryngeal mask for airway management and ventilation during sinonasal surgical procedure Laryseal Laryngeal mask airway (LMA): Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.
Overall Study
Lost to Follow-up
5
7

Baseline Characteristics

Safety and Efficacy of Laryngeal Mask Airways in Sinonasal Surgery

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Endotracheal Intubation
n=53 Participants
Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure Mallinckrodt Endotracheal Tube (ETT): Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.
Laryngeal Mask Airway
n=49 Participants
Laryngeal mask for airway management and ventilation during sinonasal surgical procedure Laryseal Laryngeal mask airway (LMA): Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.
Total
n=102 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age, Categorical
Between 18 and 65 years
35 Participants
n=99 Participants
45 Participants
n=107 Participants
80 Participants
n=206 Participants
Age, Categorical
>=65 years
18 Participants
n=99 Participants
4 Participants
n=107 Participants
22 Participants
n=206 Participants
Sex: Female, Male
Female
25 Participants
n=99 Participants
29 Participants
n=107 Participants
54 Participants
n=206 Participants
Sex: Female, Male
Male
28 Participants
n=99 Participants
20 Participants
n=107 Participants
48 Participants
n=206 Participants
Region of Enrollment
United States
53 participants
n=99 Participants
49 participants
n=107 Participants
102 participants
n=206 Participants

PRIMARY outcome

Timeframe: intraoperative, within about 1 hour

Population: Participants that started the study were analyzed. Data was missing for 1 participant in each arm.

Presence or absence of blood/secretions as noted in trachea and larynx. Patients were evaluated based on a soiling score completed by the surgeon, ranging from 0 (no contamination or soilage) to 3 (contamination of the tube/bloody secretions).

Outcome measures

Outcome measures
Measure
Endotracheal Intubation
n=52 Participants
Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure Mallinckrodt Endotracheal Tube (ETT): Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.
Laryngeal Mask Airway
n=48 Participants
Laryngeal mask for airway management and ventilation during sinonasal surgical procedure Laryseal Laryngeal mask airway (LMA): Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.
Number of Participants With Presence or Absence of Blood/Secretions in Trachea and Larynx Based on Soiling Score
Soilage score 0
12 Participants
10 Participants
Number of Participants With Presence or Absence of Blood/Secretions in Trachea and Larynx Based on Soiling Score
Soilage score 1
15 Participants
21 Participants
Number of Participants With Presence or Absence of Blood/Secretions in Trachea and Larynx Based on Soiling Score
Soilage score 2
15 Participants
10 Participants
Number of Participants With Presence or Absence of Blood/Secretions in Trachea and Larynx Based on Soiling Score
Soilage score 3
10 Participants
7 Participants

SECONDARY outcome

Timeframe: beginning and end of anesthesia (approximately 2 hours)

Start and stop time of anesthesia as recorded in anesthesia record

Outcome measures

Outcome measures
Measure
Endotracheal Intubation
n=53 Participants
Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure Mallinckrodt Endotracheal Tube (ETT): Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.
Laryngeal Mask Airway
n=49 Participants
Laryngeal mask for airway management and ventilation during sinonasal surgical procedure Laryseal Laryngeal mask airway (LMA): Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.
Anesthesia Time in Minutes
61 minutes
Interval 11.0 to 167.0
49 minutes
Interval 17.0 to 156.0

SECONDARY outcome

Timeframe: time spent in recovery room after surgery (approximately 4 hours)

Population: Participants that started the study were analyzed.

Minutes spent in recovery room as recorded in the recovery room record

Outcome measures

Outcome measures
Measure
Endotracheal Intubation
n=53 Participants
Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure Mallinckrodt Endotracheal Tube (ETT): Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.
Laryngeal Mask Airway
n=49 Participants
Laryngeal mask for airway management and ventilation during sinonasal surgical procedure Laryseal Laryngeal mask airway (LMA): Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.
Recovery Time in Minutes
PACU phase 1 time
34.5 minutes
Interval 7.0 to 111.0
30 minutes
Interval 5.0 to 112.0
Recovery Time in Minutes
PACU phase 2 time
37.5 minutes
Interval 2.0 to 181.0
40 minutes
Interval 0.0 to 220.0

SECONDARY outcome

Timeframe: From start of anesthesia through hospital discharge (approximately 6 hours)

As recorded in anesthesia care record

Outcome measures

Outcome measures
Measure
Endotracheal Intubation
n=53 Participants
Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure Mallinckrodt Endotracheal Tube (ETT): Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.
Laryngeal Mask Airway
n=49 Participants
Laryngeal mask for airway management and ventilation during sinonasal surgical procedure Laryseal Laryngeal mask airway (LMA): Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.
Presence of Laryngeal Spasm
0 Participants
0 Participants

SECONDARY outcome

Timeframe: 48 hour medicine requirement

Population: Participants that started the study were analyzed. Data was missing for 5 participants in the Endotracheal intubation arm and 7 participants in the Laryngeal mask airway arm.

Recording pain medications given to patient as noted in the recovery room records and medication administration record

Outcome measures

Outcome measures
Measure
Endotracheal Intubation
n=48 Participants
Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure Mallinckrodt Endotracheal Tube (ETT): Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.
Laryngeal Mask Airway
n=42 Participants
Laryngeal mask for airway management and ventilation during sinonasal surgical procedure Laryseal Laryngeal mask airway (LMA): Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.
Post-op Pain Med Requirements
> 15 pills
0 Participants
0 Participants
Post-op Pain Med Requirements
10-14 pills
2 Participants
3 Participants
Post-op Pain Med Requirements
5-9 pills
3 Participants
8 Participants
Post-op Pain Med Requirements
1-4 pills
21 Participants
13 Participants
Post-op Pain Med Requirements
No pain meds taken
22 Participants
18 Participants

SECONDARY outcome

Timeframe: Start of surgery through hospital discharge (approximately 6 hours)

Population: Participants that started the study were analyzed.

Outcome measures

Outcome measures
Measure
Endotracheal Intubation
n=53 Participants
Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure Mallinckrodt Endotracheal Tube (ETT): Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.
Laryngeal Mask Airway
n=49 Participants
Laryngeal mask for airway management and ventilation during sinonasal surgical procedure Laryseal Laryngeal mask airway (LMA): Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.
Presence or Absence of Airway Complications
Presence of airway complications
0 Participants
0 Participants
Presence or Absence of Airway Complications
Absence of airway complicaitons
53 Participants
49 Participants

Adverse Events

Endotracheal Intubation

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Laryngeal Mask Airway

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Justin H. Turner, MD, PhD

Vanderbilt University Medical Center

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place